KPIs & Operating Metrics(New)
Growth Metrics

Medtronic (MDT) Cash & Current Investments (2016 - 2026)

Medtronic's Cash & Current Investments history spans 14 years, with the latest figure at $8.4 billion for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 5.82% to $8.4 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $8.4 billion, a 5.82% increase, with the full-year FY2025 number at $9.0 billion, up 11.99% from a year prior.
  • Cash & Current Investments hit $8.4 billion in Q1 2026 for Medtronic, up from $8.3 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for MDT hit a ceiling of $11.4 billion in Q4 2022 and a floor of $7.7 billion in Q4 2023.
  • Historically, Cash & Current Investments has averaged $8.9 billion across 5 years, with a median of $8.3 billion in 2024.
  • Biggest five-year swings in Cash & Current Investments: plummeted 32.34% in 2023 and later increased 11.99% in 2025.
  • Tracing MDT's Cash & Current Investments over 5 years: stood at $11.4 billion in 2022, then plummeted by 32.34% to $7.7 billion in 2023, then rose by 3.3% to $8.0 billion in 2024, then rose by 4.23% to $8.3 billion in 2025, then rose by 0.67% to $8.4 billion in 2026.
  • Business Quant data shows Cash & Current Investments for MDT at $8.4 billion in Q1 2026, $8.3 billion in Q4 2025, and $8.1 billion in Q3 2025.